1. Gardasil: update from US and Australia

   News item 27 January 2013 Pages: 1 - 1

2. Health Canada issues advisories over clopidogrel/PPIs interaction

   News item 27 January 2013 Pages: 2 - 2

3. Health Canada to update TNF inhibitor labelling

   Media release 27 January 2013 Pages: 2 - 2

4. US FDA pushes for mandatory electronic AE reporting

   Media release 27 January 2013 Pages: 2 - 2

5. Health Canada issues Foreign Product Alerts for three products

   News item 27 January 2013 Pages: 3 - 3

6. NZ's Medsafe urges reporting of adverse reactions to oseltamivir, zanamivir

   News item 27 January 2013 Pages: 3 - 3

7. Sabril carries boxed warning about vision damage

   Media release 27 January 2013 Pages: 3 - 3

8. US FDA reviewing safety of orlistat

   News item 27 January 2013 Pages: 3 - 3

9. Acid-related symptoms induced by PPI withdrawal

   Clinical study 27 January 2013 Pages: 4 - 4

10. Lower AEs and associated costs with erlotinib in NSCLC treatment

    Clinical study 27 January 2013 Pages: 4 - 4

11. Pioglitazone: better cardiac safety profile than rosiglitazone

    Clinical study 27 January 2013 Pages: 4 - 4

12. Infliximab not transferred from mother to child

    Clinical study 27 January 2013 Pages: 5 - 5

13. Long-term safety analysis shows rash only AE associated with etravirine

    Clinical study 27 January 2013 Pages: 5 - 5

14. Posaconazole affects antiviral pharmacokinetics

    Clinical study 27 January 2013 Pages: 5 - 5

15. Some subgroups have increased risk of AEs with methylphenidate

    Clinical study 27 January 2013 Pages: 5 - 5

16. Acepromazine overdose

    Case report 27 January 2013 Pages: 6 - 6

17. Amantadine withdrawal

    Case report 27 January 2013 Pages: 6 - 6

18. Amisulpride/venlafaxine

    Case report 27 January 2013 Pages: 6 - 6

19. Amoxicillin/clavulanic acid

    Case report 27 January 2013 Pages: 7 - 7

20. Antiretrovirals

    Case report 27 January 2013 Pages: 7 - 7

21. Aripiprazole

    Case report 27 January 2013 Pages: 8 - 8

22. Aspirin

    Case report 27 January 2013 Pages: 8 - 8

23. Azoles

    Case report 27 January 2013 Pages: 9 - 9

24. Brimonidine

    Case report 27 January 2013 Pages: 9 - 9

25. Budesonide

    Case report 27 January 2013 Pages: 9 - 9

26. Cabergoline

    Case report 27 January 2013 Pages: 9 - 9

27. Candesartan cilexetil

    Case report 27 January 2013 Pages: 10 - 10

28. Capecitabine

    Case report 27 January 2013 Pages: 10 - 10

29. Carbamazepine

    Case report 27 January 2013 Pages: 10 - 10

30. Carbimazole/glucocorticoids

    Case report 27 January 2013 Pages: 11 - 11

31. Chlorambucil

    Case report 27 January 2013 Pages: 11 - 11

32. Ciclosporin

    Case report 27 January 2013 Pages: 11 - 11

33. Ciclosporin

    Case report 27 January 2013 Pages: 12 - 12

34. Ciclosporin/corticosteroids/hydroxychloroquine

    Case report 27 January 2013 Pages: 12 - 12

35. Cinacalcet

    Case report 27 January 2013 Pages: 12 - 12

36. Clindamycin

    Case report 27 January 2013 Pages: 13 - 13

37. Clozapine

    Case report 27 January 2013 Pages: 13 - 13

38. Clozapine

    Case report 27 January 2013 Pages: 13 - 13

39. Clozapine/topiramate withdrawal

    Case report 27 January 2013 Pages: 13 - 13

40. Cyclophosphamide/doxorubicin

    Case report 27 January 2013 Pages: 14 - 14

41. Efavirenz/Ginkgo biloba interaction

    Case report 27 January 2013 Pages: 14 - 14

42. Enoxaparin sodium

    Case report 27 January 2013 Pages: 14 - 14

43. Enoxaparin sodium/heparin

    Case report 27 January 2013 Pages: 15 - 15

44. Epinephrine

    Case report 27 January 2013 Pages: 15 - 15

45. Erlotinib

    Case report 27 January 2013 Pages: 15 - 15

46. Erlotinib

    Case report 27 January 2013 Pages: 16 - 16

47. Etanercept

    Case report 27 January 2013 Pages: 16 - 16

48. Ethanol/iodised oil

    Case report 27 January 2013 Pages: 16 - 16

49. Ethinylestradiol/drospirenone

    Case report 27 January 2013 Pages: 16 - 16

50. Fluoxetine

    Case report 27 January 2013 Pages: 17 - 17